- Home
- ATRC vs CLVT Comparison
ATRC vs CLVT Comparison
Compare ATRC & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRC | CLVT |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | United Kingdom |
| Employees | 1350 | 12000 |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATRC | CLVT |
|---|---|---|
| Price | $28.80 | $2.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $51.17 | $3.22 |
| AVG Volume (30 Days) | 736.8K | ★ 4.8M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $15.27 | N/A |
| Revenue Next Year | $12.21 | $2.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.36 | $1.66 |
| 52 Week High | $43.18 | $4.77 |
Technical Indicators
Market Signals| Indicator | ATRC | CLVT |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 30.33 |
| Support Level | $28.03 | $1.66 |
| Resistance Level | $30.49 | $2.72 |
| Average True Range (ATR) | 1.23 | 0.15 |
| MACD | 0.15 | -0.04 |
| Stochastic Oscillator | 90.89 | 11.25 |
Price Performance
Historical ComparisonAbout ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.